These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 32896462)
1. Red flags in patients with hereditary transthyretin amyloidosis at diagnosis in a non-endemic area of Spain. Silva-Hernández L; Horga Hernández A; Valls Carbó A; Guerrero Sola A; Montalvo-Moraleda MT; Galán Dávila L Neurologia (Engl Ed); 2020 Sep; ():. PubMed ID: 32896462 [TBL] [Abstract][Full Text] [Related]
2. Red flags in patients with hereditary transthyretin amyloidosis at diagnosis in a non-endemic area of Spain. Silva-Hernández L; Horga Hernández A; Valls Carbó A; Guerrero Sola A; Montalvo-Moraleda MT; Galán Dávila L Neurologia (Engl Ed); 2023 Mar; 38(2):87-92. PubMed ID: 36396096 [TBL] [Abstract][Full Text] [Related]
6. Genetic screening for hereditary transthyretin amyloidosis with polyneuropathy in western Sicily: Two years of experience in a neurological clinic. Di Stefano V; Lupica A; Alonge P; Pignolo A; Augello SM; Gentile F; Gagliardo A; Giglia F; Brinch D; Cappello M; Di Lisi D; Novo G; Borgione E; Scuderi C; Brighina F Eur J Neurol; 2024 Jan; 31(1):e16065. PubMed ID: 37725003 [TBL] [Abstract][Full Text] [Related]
7. Autonomic involvement in hereditary transthyretin amyloidosis (hATTR amyloidosis). Gonzalez-Duarte A Clin Auton Res; 2019 Apr; 29(2):245-251. PubMed ID: 29511897 [TBL] [Abstract][Full Text] [Related]
8. Phenotypes of Late-Onset Transthyretin Amyloid Neuropathy: A Diagnostic Challenge. Živković SA; Mnatsakanova D; Lacomis D J Clin Neuromuscul Dis; 2019 Sep; 21(1):1-6. PubMed ID: 31453848 [TBL] [Abstract][Full Text] [Related]
9. Canadian Guidelines for Hereditary Transthyretin Amyloidosis Polyneuropathy Management. Alcantara M; Mezei MM; Baker SK; Breiner A; Dhawan P; Fiander A; Fine NM; Hahn C; Katzberg HD; Khayambashi S; Massie R; Matte G; Putko B; Siddiqi Z; Delgado D; Bril V Can J Neurol Sci; 2022 Jan; 49(1):7-18. PubMed ID: 33631091 [TBL] [Abstract][Full Text] [Related]
10. Vutrisiran: A Review in Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis. Nie T; Heo YA; Shirley M Drugs; 2023 Oct; 83(15):1425-1432. PubMed ID: 37728865 [TBL] [Abstract][Full Text] [Related]
12. Late-Onset Hereditary Transthyretin Amyloidosis Val30Met in an Elderly Person in a Non-Endemic Area. Wang S; Sun J; Lu Q; Li H; Zhang Y Int Med Case Rep J; 2022; 15():299-306. PubMed ID: 35734096 [TBL] [Abstract][Full Text] [Related]
13. A retrospective survey of patients with hereditary transthyretin-mediated (hATTR) amyloidosis treated with patisiran in real-world clinical practice in Belgium. De Bleecker JL; Claeys KG; Delstanche S; Van Parys V; Baets J; Tilleux S; Remiche G Acta Neurol Belg; 2023 Jun; 123(3):1029-1037. PubMed ID: 36829087 [TBL] [Abstract][Full Text] [Related]
14. Carpal tunnel syndrome and associated symptoms as first manifestation of hATTR amyloidosis. Karam C; Dimitrova D; Christ M; Heitner SB Neurol Clin Pract; 2019 Aug; 9(4):309-313. PubMed ID: 31583185 [TBL] [Abstract][Full Text] [Related]
15. Development of measures of polyneuropathy impairment in hATTR amyloidosis: From NIS to mNIS + 7. Dyck PJB; González-Duarte A; Obici L; Polydefkis M; Wiesman JF; Antonino I; Litchy WJ; Dyck PJ J Neurol Sci; 2019 Oct; 405():116424. PubMed ID: 31445300 [TBL] [Abstract][Full Text] [Related]
16. Variable Presentation of Hereditary Transthyretin-Mediated Amyloidosis at a Single Center. Hussain Y J Clin Neuromuscul Dis; 2021 Sep; 23(1):7-17. PubMed ID: 34431796 [TBL] [Abstract][Full Text] [Related]
17. Familial amyloidosis with polyneuropathy type 1 caused by transthyretin mutation Val50Met (Val30Met): 4 cases in a non-endemic area. Andrés N; Poza JJ; Martí Massó JF Neurologia (Engl Ed); 2018; 33(9):583-589. PubMed ID: 27793437 [TBL] [Abstract][Full Text] [Related]
18. "Red-flag" symptom clusters in transthyretin familial amyloid polyneuropathy. Conceição I; González-Duarte A; Obici L; Schmidt HH; Simoneau D; Ong ML; Amass L J Peripher Nerv Syst; 2016 Mar; 21(1):5-9. PubMed ID: 26663427 [TBL] [Abstract][Full Text] [Related]